RNA-p53 interactions in vitro

Biochemistry

Volumn 46, Issue 9, 2007, Pages 2480-2487

  Riley, Kasandra J L ^a   Ramirez Alvarado, Marina ^a   Maher III, L James ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; BINDING ENERGY; MUTAGENESIS; PEPTIDES; PROTEINS; TUMORS;

C-TERMINAL PEPTIDES; THREE-HYBRID SYSTEM (Y3H); TUMOR SUPPRESSOR PROTEIN;

RNA;

PHOSPHORUS 32; PROTEIN P53; RNA; RNA BINDING PROTEIN; SYNTHETIC PEPTIDE; TRANSFER RNA;

ANIMAL CELL; ARTICLE; CIRCULAR DICHROISM; CROSS LINKING; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA BINDING; RNA SEQUENCE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BASE SEQUENCE; CIRCULAR DICHROISM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RNA; SPECTROPHOTOMETRY, ULTRAVIOLET; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33847674391     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061480v     Document Type: Article

References (52)

1. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., and Burd, C. G. (1993) hnRNP proteins and the biogenesis of mRNA, Annu. Rev. Biochem. 62, 289-321.
2. Herschlag, D. (1995) RNA chaperones and the RNA folding problem, J. Biol. Chem. 270, 20871-20874.
3. Ahn, J., and Prives, C. (2001) The C-terminus of p53: the more you learn the less you know, Nat. Struct. Biol. 8, 730-732.
4. Wei, C. L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Liu, J., Zhao, X. D., Chew, J. L., Lee, Y. L., Kuznetsov, V. A., Sung, W. K., Miller, L. D., Lim, B., Liu, E. T., Yu, Q., Ng, H. H., and Ruan, Y. (2006) A global map of p53 transcription-factor binding sites in the human genome, Cell 124, 207-219.
5. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis, Nat. Rev. Cancer 4, 793-805.
6. Picksley, S. M., and Lane, D. P. (1993) The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?, Bioessays 15, 689-690.
7. Oberosler, P., Hloch, P., Ramsperger, U., and Stahl, H. (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids, EMBO J. 12, 2389-2396.
8. Wu, L., Bayle, J. H., Elenbaas, B., Pavletich, N. P., and Levine, A. J. (1995) Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids, Mol. Cell. Biol. 15, 497-504.
9. Yin, X., Fontoura, B. M., Morimoto, T., and Carroll, R. B. (2003) Cytoplasmic complex of p53 and eEF2, J. Cell Physiol. 196, 474-482.
10. Fontoura, B. M., Sorokina, E. A., David, E., and Carroll, R. B. (1992) p53 is covalently linked to 5.8S rRNA, Mol. Cell. Biol. 12, 5145-5151.
11. Abou Elela, S., and Nazar, R. N. (1997) The ribosomal 5.8S RNA as a target site for p53 protein in cell differentiation and oncogenesis, Cancer Lett. 117, 23-28.
12. Cassiday, L. A., and Maher, L. J., III. (2002) Having it both ways: transcription factors that bind DNA and RNA, Nucleic Acids Res. 30, 4118-4126.
13. Riley, K. J., Cassiday, L. A., Kumar, A., and Maher, L. J., III. (2006) Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system, RNA 12, 620-630.
14. Galy, B., Creancier, L., Prado-Lourenco, L., Prats, A. C., and Prats, H. (2001) p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA, Oncogene 20, 4613-4620.
15. Miller, S. J., Suthiphongchai, T., Zambetti, G. P., and Ewen, M. E. (2000) p53 binds selectively to the 5′ untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4, Mol. Cell. Biol. 20, 8420-8431.
16. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W. (1995) Negative feedback regulation of wild-type p53 biosynthesis, EMBO J. 14, 4442-4449.
17. Jayaraman, J., and Prives, C. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus, Cell 81, 1021-1029.
18. Weinberg, R. L., Veprintsev, D. B., and Fersht, A. R. (2004) Cooperative binding of tetrameric p53 to DNA, J. Mol. Biol. 341, 1145-1159.
19. Friedman, P. N., Chen, X., Bargonetti, J., and Prives, C. (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA, Proc. Natl. Acad. Sci. U.S.A. 90, 3319-3323.
20. Anderson, M. E., Woelker, B., Reed, M., Wang, P., and Tegtmeyer, P. (1997) Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation, Mol. Cell. Biol. 17, 6255-6264.
21. Krummel, K. A., Lee, C. J., Toledo, F., and Wahl, G. M. (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation, Proc. Natl. Acad. Sci. U.S.A. 102, 10188-10193.
22. Brooks, C. L., and Gu, W. (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation, Curr. Opin. Cell Biol. 15, 164-171.
23. Friedler, A., Veprintsev, D. B., Freund, S. M., von Glos, K. I., and Fersht, A. R. (2005) Modulation of binding of DNA to the C-terminal domain of p53 by acetylation, Structure (Cambridge, MA, U.S.) 13, 629-636.
24. Spolar, R. S., and Record, M. T., Jr. (1994) Coupling of local folding to site-specific binding of proteins to DNA, Science 263, 777-784.
25. Fasman, G. D., Ed. (1996) Circular Dichroism and the Conformational Analysis of Biomolecules, Plenum Press, New York.
26. Yakovleva, T., Pramanik, A., Kawasaki, T., Tan-No, K., Gileva, I., Lindegren, H., Langel, U., Ekstrom, T. J., Rigler, R., Terenius, L., and Bakalkin, G. (2001) p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences, J. Biol. Chem. 276, 15650-15658.
27. Wolcke, J., Reimann, M., Klumpp, M., Gohler, T., Kim, E., and Deppert, W. (2003) Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding, J. Biol. Chem. 278, 32587-32595.
28. Bell, S., Klein, C., Muller, L., Hansen, S., and Buchner, J. (2002) p53 contains large unstructured regions in its native state, J. Mol. Biol. 322, 917-927.
29. Ljungman, M., and Lane, D. P. (2004) Transcription-guarding the genome by sensing DNA damage, Nat. Rev. Cancer 4, 727-737.
30. O'Hagan, H. M., and Ljungman, M. (2004) Efficient NES-dependent protein nuclear export requires ongoing synthesis and export of mRNAs, Exp. Cell Res. 297, 548-559.
31. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., and Wahl, G. M. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking, EMBO J. 18, 1660-1672.
32. Zhang, Y., and Xiong, Y. (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation, Science 292, 1910-1915.
33. Mueller, A., Schafer, B. W., Ferrari, S., Weibel, M., Makek, M., Hochli, M., and Heizmann, C. W. (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity, J. Biol. Chem. 280, 29186-29193.
34. Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Yoshida, T., Itoh, H., and Kohno, K. (2004) Binding of RNA to p53 regulates its oligomerization and DNA-binding activity, Oncogene 23, 4371-4379.
35. Yakovleva, T., Pramanik, A., Terenius, L., Ekstrom, T. J., and Bakalkin, G. (2002) p53 latency-out of the blind alley, Trends Biochem. Sci. 27, 612-618.
36. Kaeser, M. D., and Iggo, R. D. (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl. Acad. Sci. U.S.A. 99, 95-100.
37. Ayed, A., Mulder, F. A., Yi, G. S., Lu, Y., Kay, L. E., and Arrowsmith, C. H. (2001) Latent and active p53 are identical in conformation, Nat. Struct. Biol. 8, 756-760.
38. Hansen, S., Lane, D. P., and Midgley, C. A. (1998) The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability, J. Mol. Biol. 275, 575-588.
39. McKinney, K., and Prives, C. (2002) Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein, Mol. Cell. Biol. 22, 6797-6808.
40. Hansen, S., Midgley, C. A., Lane, D. P., Freeman, B. C., Morimoto, R. I., and Hupp, T. R. (1996) Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70, J. Biol. Chem. 271, 30922-30928.
41. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell 90, 595-606.
42. Prives, C., and Manley, J. L. (2001) Why is p53 acetylated?, Cell 107, 815-818.
43. Weinberg, R. L., Freund, S. M., Veprintsev, D. B., Bycroft, M., and Fersht, A. R. (2004) Regulation of DNA binding of p53 by its C-terminal domain, J. Mol. Biol. 342, 801-811.
44. Chiarugi, V., Cinelli, M., and Magnelli, L. (1998) Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance, Oncol. Res. 10, 55-57.
45. Feng, L., Lin, T., Uranishi, H., Gu, W., and Xu, Y. (2005) Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity, Mol. Cell. Biol. 25, 5389-5395.
46. Royds, J. A., and Iacopetta, B. (2006) p53 and disease: when the guardian angel fails, Cell Death Differ. 13, 1017-1026.
47. Agirre, X., Novo, F. J., Calasanz, M. J., Larrayoz, M. J., Lahortiga, I., Valganon, M., Garcia-Delgado, M., and Vizmanos, J. L. (2003) TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia, Mol. Carcinog. 38, 201-208.
48. Balz, V., Scheckenbach, K., Gotte, K., Bockmuhl, U., Petersen, I., and Bier, H. (2003) Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens, Cancer Res. 63, 1188-1191.
49. Hayes, V. M., Bleeker, W., Verlind, E., Timmer, T., Karrenbeld, A., Plukker, J. T., Marx, M. P., Hofstra, R. M., and Buys, C. H. (1999) Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue, Diagn. Mol. Pathol. 8, 2-10.
50. Husgafvel-Pursiainen, K., Boffetta, P., Kannio, A., Nyberg, F., Pershagen, G., Mukeria, A., Constantinescu, V., Fortes, C., and Benhamou, S. (2000) p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer, Cancer Res. 60, 2906-2911.
51. Hwang, S. J., Lozano, G., Amos, C. I., and Strong, L. C. (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk, Am. J. Hum. Genet. 72, 975-983.
52. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas, Cancer Res. 51, 5520-5525.